Start Date
Immediate
Expiry Date
06 Nov, 25
Salary
0.0
Posted On
07 Aug, 25
Experience
0 year(s) or above
Remote Job
Yes
Telecommute
Yes
Sponsor Visa
No
Skills
Development Strategy, Editing, Creativity, Liver Disease, Emotional Intelligence, Team Leadership, Human Genetics, Therapeutic Modalities, Targeted Therapies
Industry
Pharmaceuticals
ABOUT US
Deep Genomics is at the forefront of using artificial intelligence to transform drug discovery. Our proprietary AI platform decodes the complexity of RNA biology to identify novel drug targets, mechanisms, and therapeutics inaccessible through traditional methods. With expertise spanning machine learning, bioinformatics, data science, and high throughput screening, our multidisciplinary team in Toronto and Cambridge, MA is revolutionizing how new medicines are created.
BASIC QUALIFICATIONS
PREFERRED QUALIFICATIONS
ABOUT THE ROLE
The Principal Scientist, in vivo pharmacology will be responsible for establishing and leading the in vivo pharmacology function at Deep Genomics with the goal of advancing RNA editing therapeutics. This is a leadership role with the opportunity to make a significant impact on Deep Genomics’ therapeutic pipeline. Success in this role requires the ability to lead strategically, execute tactically, and influence others in a highly matrixed and multidisciplinary team.
The ideal candidate will have direct experience in designing, executing and interpreting translational studies for the development of genetic medicines in mice and NHP. Direct experience with ADAR, ASOs, siRNAs or gene editing is highly beneficial. Experience with LNP- and GalNAc-mediated delivery is essential. Experience with liver and metabolic disease and relevant pre-clinical models is highly desired but the candidate will be expected to expand into other diseases and tissues as the company’s therapeutic pipeline matures. This role requires fluency in leading studies with external research organizations and acting as a connector between internal groups. In addition to leading in vivo work, the candidate is expected to work closely with the Platform Biology team to provide input on relevant in vitro model systems.
In addition to setting and executing the strategy for pre-clinical work, the candidate will be expected to contribute to the clinical development path, including planning and writing regulatory submissions and biomarker development in collaboration with internal leaders and external consultants and KOLs.
As a key member of an early stage discovery team, this individual must demonstrate initiative and ownership in both scientific and strategic decisions and have an entrepreneurial mindset. Ability to pro-actively anticipate needs and independently seek solutions is a key skill, together with effective communication in all directions. This role may lead to the opportunity to manage and mentor direct reports in the future. Please note that the title is commensurate with prior experience.
KEY RESPONSIBILITIES